Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer

European Journal of Cancer

Volumn 62, Issue , 2016, Pages 103-111

  Yoshikawa, Takaki ^a   Morita, Satoshi ^b   Tanabe, Kazuaki ^c   Nishikawa, Kazuhiro ^d   Ito, Yuichi ^e   Matsui, Takanori ^e   Fujitani, Kazumasa ^f   Kimura, Yutaka ^g   Fujita, Junya ^h   Aoyama, Toru ^a   Hayashi, Tsutomu ^a   Cho, Haruhiko ^a   Tsuburaya, Akira ⁱ   Miyashita, Yumi ^j   Sakamoto, Junichi ^k  

^a KANAGAWA CANCER CENTER   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d OSAKA NATIONAL HOSPITAL   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f OSAKA GENERAL MEDICAL CENTER   (Japan)

^g Sakai City Medical Center   (Japan)

^h OSAKA POLICE HOSPITAL   (Japan)

ⁱ YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^j Nonprofit Organization ECRIN   (Japan)

^k Tokai Central Hospital of Japan Mutual Aid Association of Public School Teachers   (Japan)

more..

Author keywords

chemotherapy; duration; Gastric cancer; neoadjuvant; surgery; survival

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; PACLITAXEL; ANTINEOPLASTIC AGENT; DRUG COMBINATION; OTERACIL; S 1 (COMBINATION); TEGAFUR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FACTORIAL DESIGN; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; STOMACH CANCER; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; MULTIMODALITY CANCER THERAPY; NEOADJUVANT THERAPY; PROCEDURES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; OXONIC ACID; PACLITAXEL; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TEGAFUR;

EID: 84971426947     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.04.012     Document Type: Article

References (28)

1. GLOBOCAN2012 Estimated cancer incidence, mortality and prevalence worldwide in 2012 2012
2. T. Yoshikawa, and M. Sasako Gastrointestinal cancer: adjuvant chemotherapy after D2 gastrectomy for gastric cancer Nat Rev Clin Oncol 9 4 2012 192 194
3. S. Sakuramoto, M. Sasako, T. Yamaguchi, T. Kinoshita, M. Fujii, A. Nashimoto, and et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 18 2007 1810 1820
4. Y.J. Bang, Y.W. Kim, H.K. Yang, H.C. Chung, Y.K. Park, K.H. Lee, and et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet 379 9813 2012 315 321
5. M. Sasako, S. Sakuramoto, H. Katai, T. Kinoshita, H. Furukawa, T. Yamaguchi, and et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer J Clin Oncol 29 33 2011 4387 4393
6. D. Cunningham, W.H. Allum, S.P. Stenning, J.N. Thompson, C.J. Van de Velde, M. Nicolson, and et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 1 2006 11 20
7. A. Okines, M. Verheij, W. Allum, D. Cunningham, A. Cervantes, and E.G.W. Group Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl. 5 2010 v50 v54
8. M. Ychou, V. Boige, J.P. Pignon, T. Conroy, O. Bouche, G. Lebreton, and et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 13 2011 1715 1721
9. K. Ng, J.A. Meyerhardt, and C.S. Fuchs Adjuvant and neoadjuvant approaches in gastric cancer Cancer J 13 3 2007 168 174
10. Japanese Gastric Cancer A Japanese gastric cancer treatment guidelines 2010 (ver. 3) Gastric Cancer 14 2 2011 113 123
11. W. Koizumi, H. Narahara, T. Hara, A. Takagane, T. Akiya, M. Takagi, and et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 3 2008 215 221
12. D. Takahari, T. Hamaguchi, K. Yoshimura, H. Katai, S. Ito, N. Fuse, and et al. Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer Cancer Chemother Pharmacol 67 6 2011 1423 1428
13. Y. Kodera, A. Ishiyama, T. Yoshikawa, T. Kinoshita, S. Ito, H. Yokoyama, and et al. A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703) Gastric Cancer 13 3 2010 197 203
14. K. Inoue, Y. Nakane, M. Kogire, K. Fujitani, Y. Kimura, H. Imamura, and et al. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer Eur J Surg Oncol 38 2 2012 143 149
15. A. Nashimoto, H. Yabusaki, S. Nakagawa, Y. Takii, Y. Tsuchiya, and T. Otsuo Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer Anticancer Res 29 11 2009 4689 4696
16. T. Yoshikawa, K. Omura, O. Kobayashi, A. Nashimoto, A. Takabayashi, T. Yamada, and et al. A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study) Eur J Surg Oncol 36 6 2010 546 551
17. N. Nagata, M. Kimura, N. Hirabayashi, A. Tuburaya, T. Murata, K. Kondo, and et al. Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancer Hepatogastroenterology 55 86-87 2008 1846 1850
18. J. Sakamoto, T. Matsui, and Y. Kodera Paclitaxel chemotherapy for the treatment of gastric cancer Gastric Cancer 12 2 2009 69 78
19. A. Tsuburaya, N. Nagata, H. Cho, N. Hirabayashi, M. Kobayashi, H. Kojima, and et al. Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer Cancer Chemother Pharmacol 71 5 2013 1309 1314
20. T. Yoshikawa, M. Sasako, S. Yamamoto, T. Sano, H. Imamura, K. Fujitani, and et al. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer Br J Surg 96 9 2009 1015 1022
21. T. Yoshikawa, A. Tsuburaya, S. Morita, Y. Kodera, S. Ito, H. Cho, and et al. A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS) Jpn J Clin Oncol 40 4 2010 369 372
22. T. Yoshikawa, K. Tanabe, K. Nishikawa, Y. Ito, T. Matsui, Y. Kimura, and et al. Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial Ann Surg Oncol 21 1 2014 213 219
23. L.H. Sobin, M.K. Gospodarowicz, and C.H. Witterkind International Union Against Cancer (UICC) TNM classification of malignant tumors 7th ed. 2009 Wiley-Black-well Oxford, UK
24. T. Yoshikawa, Y. Rino, N. Yukawa, T. Oshima, A. Tsuburaya, and M. Masuda Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy Surg Today 44 1 2014 11 21
25. A. Tsuburaya, K. Yoshida, M. Kobayashi, S. Yoshino, M. Takahashi, N. Takiguchi, and et al. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial Lancet Oncol 15 8 2014 886 893
26. W. Koizumi, Y.H. Kim, M. Fujii, H.K. Kim, H. Imamura, K.H. Lee, and et al. Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START) J Cancer Res Clin Oncol 140 2 2014 319 328
27. S. Hasegawa, T. Yoshikawa, J. Shirai, H. Fujikawa, H. Cho, T. Doiuchi, and et al. A prospective validation study to diagnose serosal invasion and nodal metastases of gastric cancer by multidetector-row CT Ann Surg Oncol 20 6 2013 2016 2022
28. A. Tsuburaya, J. Mizusawa, Y. Tanaka, N. Fukushima, A. Nashimoto, M. Sasako, and et al. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis Br J Surg 101 6 2014 653 660